Standard
OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors. / Brahe, C.h.; Krabbe, S.; Østergaard, M.; Ørnbjerg, L.; Glinatsi, D.; Røgind, H.; Jensen, H.S.; Hansen, A.; Nørregaard, J.; Jacobsen, S.; Terslev, L.; Huynh, T.k.; Jensen, D.v.; Manilo, N.; Asmussen, K.; Frandsen, P.b.; Boesen, M.; Rastiemadabadi, Z.; Carlsen, L. M.; Møller, J.; Krogh, N.s.; Hetland, M.l.
2018. 70-71.
Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › fagfællebedømt
Harvard
Brahe, CH, Krabbe, S
, Østergaard, M, Ørnbjerg, L, Glinatsi, D, Røgind, H, Jensen, HS, Hansen, A, Nørregaard, J, Jacobsen, S
, Terslev, L, Huynh, TK, Jensen, DV, Manilo, N, Asmussen, K, Frandsen, PB
, Boesen, M, Rastiemadabadi, Z, Carlsen, LM, Møller, J, Krogh, NS
& Hetland, ML 2018, '
OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors', s. 70-71.
https://doi.org/10.1136/annrheumdis-2018-eular.2901APA
Brahe, C. H., Krabbe, S.
, Østergaard, M., Ørnbjerg, L., Glinatsi, D., Røgind, H., Jensen, H. S., Hansen, A., Nørregaard, J., Jacobsen, S.
, Terslev, L., Huynh, T. K., Jensen, D. V., Manilo, N., Asmussen, K., Frandsen, P. B.
, Boesen, M., Rastiemadabadi, Z., Carlsen, L. M.
, ... Hetland, M. L. (2018).
OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors. 70-71.
https://doi.org/10.1136/annrheumdis-2018-eular.2901Vancouver
Brahe CH, Krabbe S
, Østergaard M, Ørnbjerg L, Glinatsi D, Røgind H o.a..
OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors. 2018.
https://doi.org/10.1136/annrheumdis-2018-eular.2901Author
Brahe, C.h. ; Krabbe, S. ; Østergaard, M. ; Ørnbjerg, L. ; Glinatsi, D. ; Røgind, H. ; Jensen, H.S. ; Hansen, A. ; Nørregaard, J. ; Jacobsen, S. ; Terslev, L. ; Huynh, T.k. ; Jensen, D.v. ; Manilo, N. ; Asmussen, K. ; Frandsen, P.b. ; Boesen, M. ; Rastiemadabadi, Z. ; Carlsen, L. M. ; Møller, J. ; Krogh, N.s. ; Hetland, M.l. / OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors. 2 s.
Bibtex
@conference{fb11fba86c864f15a3a1719584e37864,
title = "OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors",
author = "C.h. Brahe and S. Krabbe and M. {\O}stergaard and L. {\O}rnbjerg and D. Glinatsi and H. R{\o}gind and H.S. Jensen and A. Hansen and J. N{\o}rregaard and S. Jacobsen and L. Terslev and T.k. Huynh and D.v. Jensen and N. Manilo and K. Asmussen and P.b. Frandsen and M. Boesen and Z. Rastiemadabadi and Carlsen, {L. M.} and J. M{\o}ller and N.s. Krogh and M.l. Hetland",
year = "2018",
doi = "10.1136/annrheumdis-2018-eular.2901",
language = "English",
pages = "70--71",
}
RIS
TY - ABST
T1 - OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors
AU - Brahe, C.h.
AU - Krabbe, S.
AU - Østergaard, M.
AU - Ørnbjerg, L.
AU - Glinatsi, D.
AU - Røgind, H.
AU - Jensen, H.S.
AU - Hansen, A.
AU - Nørregaard, J.
AU - Jacobsen, S.
AU - Terslev, L.
AU - Huynh, T.k.
AU - Jensen, D.v.
AU - Manilo, N.
AU - Asmussen, K.
AU - Frandsen, P.b.
AU - Boesen, M.
AU - Rastiemadabadi, Z.
AU - Carlsen, L. M.
AU - Møller, J.
AU - Krogh, N.s.
AU - Hetland, M.l.
PY - 2018
Y1 - 2018
U2 - 10.1136/annrheumdis-2018-eular.2901
DO - 10.1136/annrheumdis-2018-eular.2901
M3 - Conference abstract for conference
SP - 70
EP - 71
ER -
